Rein Therapeutics Inc (RNTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $47.63M
Last updated: Nov 17, 2026 at 11:04 AM ET
Rein Therapeutics Inc (RNTX) Earnings: Report Dates and Results
Rein Therapeutics (RNTX) is expected to report earnings on Mar 24, 2027. In the quarter ended Jun 30, 2026, Rein Therapeutics reported EPS of -$0.10, above the -$0.27 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
RNTX has an expected report date of Mar 24, 2027.
Earnings History
Of the 34 quarters below that had an estimate, RNTX beat 15, missed 17 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2023, when EPS landed 862.50% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.10 | -$0.27 | -$0.27 - -$0.07 | +62.96% | Beat | N/A | 2 | 1 up, 0 down | Aug 14, 2026 |
| Mar 31, 2026 | -$0.19 | -$0.49 | -$0.49 - -$0.49 | +61.22% | Beat | N/A | 1 | 0 up, 0 down | May 15, 2026 |
| Dec 31, 2025 | -$1.22 | -$0.22 | -$0.24 - -$0.19 | -467.44% | Miss | N/A | 2 | N/A | Mar 26, 2026 |
| Sep 30, 2025 | -$0.21 | -$0.24 | -$0.26 - -$0.22 | +12.50% | Beat | N/A | 2 | 0 up, 0 down | Nov 14, 2025 |
| Jun 30, 2025 | -$0.28 | -$0.22 | N/A | -27.27% | Miss | N/A | N/A | N/A | Aug 14, 2025 |
| Mar 31, 2025 | -$0.25 | -$0.21 | N/A | -19.05% | Miss | N/A | N/A | 0 up, 0 down | Apr 7, 2025 |
| Dec 31, 2024 | -$0.26 | -$0.48 | -$0.48 - -$0.48 | +45.56% | Beat | N/A | 1 | 0 up, 0 down | Dec 31, 2024 |
| Sep 30, 2024 | -$0.27 | -$0.35 | N/A | +22.86% | Beat | N/A | N/A | N/A | Nov 14, 2024 |
| Jun 30, 2024 | -$0.45 | -$0.42 | N/A | -7.14% | Miss | N/A | N/A | N/A | Aug 14, 2024 |
| Mar 31, 2024 | -$0.86 | -$1.02 | N/A | +15.69% | Beat | N/A | N/A | N/A | May 15, 2024 |
| Dec 31, 2023 | -$1.54 | -$0.16 | N/A | -862.50% | Miss | N/A | N/A | N/A | Dec 31, 2023 |
| Sep 30, 2023 | -$0.40 | -$0.20 | N/A | -100.00% | Miss | N/A | N/A | N/A | Oct 13, 2023 |
| Jun 30, 2023 | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 8, 2023 |
| Mar 31, 2023 | -$1.05 | -$0.60 | N/A | -75.00% | Miss | N/A | N/A | N/A | May 8, 2023 |
| Dec 31, 2022 | -$1.00 | -$1.34 | N/A | +25.37% | Beat | N/A | N/A | N/A | Mar 20, 2023 |
| Sep 30, 2022 | -$1.40 | -$1.60 | N/A | +12.50% | Beat | N/A | N/A | N/A | Nov 1, 2022 |
| Jun 30, 2022 | -$1.80 | -$1.90 | N/A | +5.26% | Beat | N/A | N/A | N/A | Aug 15, 2022 |
| Mar 31, 2022 | -$1.80 | -$1.60 | N/A | -12.50% | Miss | N/A | N/A | N/A | May 5, 2022 |
| Dec 31, 2021 | -$0.08 | -$0.08 | N/A | 0.00% | In line | N/A | N/A | N/A | Mar 28, 2022 |
| Sep 30, 2021 | -$1.40 | -$1.40 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 12, 2021 |
| Jun 30, 2021 | -$1.20 | -$1.40 | N/A | +14.29% | Beat | N/A | N/A | N/A | Aug 11, 2021 |
| Mar 31, 2021 | -$1.60 | -$1.10 | N/A | -45.45% | Miss | N/A | N/A | N/A | May 11, 2021 |
| Dec 31, 2020 | -$0.12 | -$0.13 | N/A | +5.81% | Beat | N/A | N/A | N/A | Mar 24, 2021 |
| Sep 30, 2020 | -$2.60 | -$2.75 | N/A | +5.45% | Beat | N/A | N/A | N/A | Nov 12, 2020 |
| Jun 30, 2020 | -$2.80 | -$3.73 | N/A | +24.93% | Beat | N/A | N/A | N/A | Aug 5, 2020 |
| Mar 31, 2020 | -$4.80 | -$4.20 | N/A | -14.29% | Miss | N/A | N/A | N/A | May 11, 2020 |
| Dec 31, 2019 | -$0.26 | -$0.27 | N/A | +3.70% | Beat | N/A | N/A | N/A | Mar 30, 2020 |
| Sep 30, 2019 | -$5.60 | -$4.75 | N/A | -17.89% | Miss | N/A | N/A | N/A | Nov 7, 2019 |
| Jun 30, 2019 | -$5.20 | -$4.45 | N/A | -16.85% | Miss | N/A | N/A | N/A | Aug 6, 2019 |
| Mar 31, 2019 | -$9.80 | -$7.75 | N/A | -26.45% | Miss | N/A | N/A | N/A | May 8, 2019 |
| Sep 30, 2018 | -$10.00 | -$11.10 | N/A | +9.91% | Beat | N/A | N/A | N/A | Nov 7, 2018 |
| Jun 30, 2018 | -$12.80 | -$10.40 | N/A | -23.08% | Miss | N/A | N/A | N/A | Aug 7, 2018 |
| Mar 31, 2018 | -$10.40 | -$10.00 | N/A | -4.00% | Miss | N/A | N/A | N/A | May 9, 2018 |
| Sep 30, 2017 | -$9.00 | -$6.90 | N/A | -30.43% | Miss | N/A | N/A | N/A | Nov 9, 2017 |
| Jun 30, 2017 | -$8.27 | -$8.20 | N/A | -0.85% | Miss | N/A | N/A | N/A | Aug 10, 2017 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.96, after -$1.84 the year before. It was -$71.33 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.96 | N/A |
| Dec 31, 2024 | -$1.84 | N/A |
| Dec 31, 2023 | -$3.38 | N/A |
| Dec 31, 2022 | -$6.00 | N/A |
| Dec 31, 2021 | -$4.28 | N/A |
| Dec 31, 2020 | -$10.32 | N/A |
| Dec 31, 2019 | -$71.33 | N/A |
Frequently Asked Questions About RNTX
When is Rein Therapeutics's next earnings date?
Rein Therapeutics's next earnings report is expected for Mar 24, 2027.
Did RNTX beat earnings estimates last quarter?
Yes. Rein Therapeutics reported EPS of -$0.10 for the quarter ended Jun 30, 2026, above the -$0.27 estimate, a 62.96% surprise.
What EPS do analysts expect from RNTX next quarter?
The consensus EPS estimate for Rein Therapeutics for the quarter ending Dec 31, 2026 is -$0.13 from 4 analysts, with estimates from -$0.15 to -$0.11.
How often does RNTX beat earnings estimates?
Rein Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -38.58%.
RNTX pages: Overview, Earnings, Forecast, Financials, Competitors